About Seralab
Seralab is a Healthcare company based in Haywards Heath (United Kingdom) founded in 1998, and was acquired by BioIVT in July 2014. It manufactures reagents for cell and molecular biology. The company has 54 employees. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its legal entity is SERA LABORATORIES INTERNATIONAL LIMITED.
Company details
Seralab engages in manufacturing research reagents for life sciences. The product portfolio of the company includes normal human animal matrices (blood products and normal human animal tissues), disease state matrices tissues (disease state matrices, disease state tissues), hepatocytes microsomes S9 hepatocytes, microsomes S9 custom cell), cell culture sera media (reagents growth factors, bovine serum albumin HSA human serum foetal bovine serum).
- Headquarters Haywards Heath, United Kingdom
- Employees 54
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website seralab.co.uk
- Acquired by BioIVT (Jul 2014)
- Legal Name Sera Laboratories International Limited
- Date of Incorporation 01 Jun, 1998
- Jurisdiction LONDON, UNITED KINGDOM
Investors in Seralab
Seralab has secured backing from 1 investor. Prominent investors backing the company include BioIVT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of in vitro diagnostic products and assay services | 2015 | bioivt.com | Westbury, United States |
Investor details for Seralab
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Seralab
1 people are tracked at Seralab (1 in leadership); the tracked headcount is 54.
| Name | Role | Group |
|---|---|---|
Jenny Murray | Owner and Managing Director | Leadership |
Complete people profiles for Seralab
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Seralab
2 dated milestones of Seralab across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Seralab is founded.
- Exit Acquired by BioIVT.
Web traffic of Seralab
Websites that share an audience with Seralab (seralab.co.uk).
Websites whose visitors overlap most with Seralab. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| eylabs.com | 100% | #5,913,034 | View details | ||
| immunostep.com | 66% | 8.9K | #2,544,993 | View details | |
| innov-research.com | 49% | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Seralab (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Seralab
Complete news archive for Seralab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Seralab
Seralab was founded in 1998.
Seralab is headquartered in Haywards Heath, United Kingdom. It is registered at Haywards Heath, England, United Kingdom.
Seralab has 54 employees.
Annual revenue of Seralab is $20.77M as on Dec 31, 2021.
Seralab engages in manufacturing research reagents for life sciences. The product portfolio of the company includes normal human animal matrices (blood products and normal human animal tissues), disease state matrices tissues (disease state matrices, disease state tissues), hepatocytes microsomes S9 hepatocytes, microsomes S9 custom cell), cell culture sera media (reagents growth factors, bovine serum albumin HSA human serum foetal bovine serum).
Seralab has 1 investor. Key investors include BioIVT.
Seralab operates through Sera Laboratories International Limited.
Yes. Seralab was acquired by BioIVT in July 2014.